Cipher Pharmaceuticals (CPH) Competitors

Cipher Pharmaceuticals (TSE:CPH) and Cronos Group (TSE:CRON) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, community ranking, risk, analyst recommendations, media sentiment, dividends, profitability, valuation and earnings.

Is CPH or CRON more profitable?

Cipher Pharmaceuticals has a net margin of 102.01% compared to Cronos Group's net margin of -56.43%. Cipher Pharmaceuticals' return on equity of 28.43% beat Cronos Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cipher Pharmaceuticals	102.01%	28.43%	7.90%
Cronos Group	-56.43%	-5.29%	-3.73%

Does the MarketBeat Community prefer CPH or CRON?

Cipher Pharmaceuticals received 112 more outperform votes than Cronos Group when rated by MarketBeat users. Likewise, 62.20% of users gave Cipher Pharmaceuticals an outperform vote while only 50.74% of users gave Cronos Group an outperform vote.

Company	Underperform	Outperform
Cipher Pharmaceuticals	Outperform Votes 181 62.20%	Underperform Votes 110 37.80%
Cronos Group	Outperform Votes 69 50.74%	Underperform Votes 67 49.26%

Do analysts prefer CPH or CRON?

Cipher Pharmaceuticals presently has a consensus target price of C$12.50, suggesting a potential downside of 14.91%. Cronos Group has a consensus target price of C$3.18, suggesting a potential upside of 13.98%. Given Cronos Group's higher probable upside, analysts clearly believe Cronos Group is more favorable than Cipher Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cipher Pharmaceuticals	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	3.00
Cronos Group	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Which has higher earnings and valuation, CPH or CRON?

Cipher Pharmaceuticals has higher earnings, but lower revenue than Cronos Group. Cronos Group is trading at a lower price-to-earnings ratio than Cipher Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cipher Pharmaceuticals	C$22.16M	16.96	C$22.60M	C$1.25	11.75
Cronos Group	C$101.78M	10.48	-C$57.37M	-C$0.21	-13.29

Does the media refer more to CPH or CRON?

In the previous week, Cronos Group had 3 more articles in the media than Cipher Pharmaceuticals. MarketBeat recorded 3 mentions for Cronos Group and 0 mentions for Cipher Pharmaceuticals. Cronos Group's average media sentiment score of 0.44 beat Cipher Pharmaceuticals' score of 0.00 indicating that Cronos Group is being referred to more favorably in the news media.

Company	Overall Sentiment
Cipher Pharmaceuticals	Neutral
Cronos Group	Neutral

Which has more risk and volatility, CPH or CRON?

Cipher Pharmaceuticals has a beta of 1.2, suggesting that its share price is 20% more volatile than the S&P 500. Comparatively, Cronos Group has a beta of 1.02, suggesting that its share price is 2% more volatile than the S&P 500.

Do institutionals & insiders have more ownership in CPH or CRON?

1.4% of Cipher Pharmaceuticals shares are owned by institutional investors. Comparatively, 16.0% of Cronos Group shares are owned by institutional investors. 42.0% of Cipher Pharmaceuticals shares are owned by company insiders. Comparatively, 46.4% of Cronos Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Cipher Pharmaceuticals beats Cronos Group on 13 of the 19 factors compared between the two stocks.